Invention Grant
- Patent Title: Targeted cytokine for treatment of musculoskeletal diseases
- Patent Title (中): 用于治疗肌肉骨骼疾病的靶向细胞因子
-
Application No.: US14006944Application Date: 2012-03-21
-
Publication No.: US09289513B2Publication Date: 2016-03-22
- Inventor: Tod Lauerman
- Applicant: Tod Lauerman
- Applicant Address: US CA Vista
- Assignee: OPTION PHARMACEUTICALS, LLC
- Current Assignee: OPTION PHARMACEUTICALS, LLC
- Current Assignee Address: US CA Vista
- Agency: Morrsion & Foerster LLP
- International Application: PCT/US2012/029983 WO 20120321
- International Announcement: WO2012/129330 WO 20120927
- Main IPC: A61K38/18
- IPC: A61K38/18 ; A61K47/42 ; A61K47/48 ; C07K14/495

Abstract:
Provided are proteins and polynucleotides, complexes and compositions containing the proteins, and methods for their use in administration to subjects and for disease treatment. Among the provided proteins and complexes are complexes containing a TGF-beta associated with immunoglobulins (such as IgGs) or functional portions thereof including Fc portions, such as by non-covalent bonds. The complexes and compositions can be used for administration to subjects, such as for treating a subject with a musculoskeletal disease such as osteoarthritis and/or degenerative joint disease. The complexes and compositions can be used in different mammals, including dogs, horses, and humans.
Public/Granted literature
- US20140170171A1 TARGETED CYTOKINE FOR TREATMENT OF MUSCULOSKELETAL DISEASES Public/Granted day:2014-06-19
Information query
IPC分类: